MFN2 and neoplasm: Furthermore, disrupted mitochondrial function associated with PDAC and reduced mitochondrial oxidative phosphorylation (OXPHOS) by enhancing mitochondrial fusion, through dynamin-related protein-1 (Drp1) inhibition or mitofusin-2 (Mfn2) overexpression, is associated with tumor growth suppression and improved survival.